JPS59216597A - 新生理活性物質ヒスタジン - Google Patents

新生理活性物質ヒスタジン

Info

Publication number
JPS59216597A
JPS59216597A JP58089075A JP8907583A JPS59216597A JP S59216597 A JPS59216597 A JP S59216597A JP 58089075 A JP58089075 A JP 58089075A JP 8907583 A JP8907583 A JP 8907583A JP S59216597 A JPS59216597 A JP S59216597A
Authority
JP
Japan
Prior art keywords
histadine
culture
medium
active substance
histargin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58089075A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0358342B2 (en, 2012
Inventor
Hamao Umezawa
梅沢　浜夫
Tomio Takeuchi
富雄 竹内
Takaaki Aoyanagi
青柳　高明
Masa Hamada
雅 浜田
Keiji Ogawa
小川　慶治
Hironobu Iinuma
寛信 飯沼
Akira Obayashi
晃 大林
Mitsugi Hachisu
蜂須　貢
Kenji Kawamura
川村　研治
Taro Niida
仁井田　太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to JP58089075A priority Critical patent/JPS59216597A/ja
Priority to EP84105601A priority patent/EP0127076A3/en
Priority to GR74769A priority patent/GR82026B/el
Priority to ZA843846A priority patent/ZA843846B/xx
Priority to DK251384A priority patent/DK251384A/da
Publication of JPS59216597A publication Critical patent/JPS59216597A/ja
Publication of JPH0358342B2 publication Critical patent/JPH0358342B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP58089075A 1983-05-23 1983-05-23 新生理活性物質ヒスタジン Granted JPS59216597A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP58089075A JPS59216597A (ja) 1983-05-23 1983-05-23 新生理活性物質ヒスタジン
EP84105601A EP0127076A3 (en) 1983-05-23 1984-05-17 Histargin, a microbiological process for its preparation, its use as a medicament, and the strain streptomyces roseoviridis having the ability to produce histargin
GR74769A GR82026B (en, 2012) 1983-05-23 1984-05-21
ZA843846A ZA843846B (en) 1983-05-23 1984-05-22 Histargin,a microbiological process for its preparation,its use as a medicament,and the strain streptomyces roseoviridis having the ability to produce histargin
DK251384A DK251384A (da) 1983-05-23 1984-05-22 Histargin samt fremgangsmaade til fremstilling heraf ud fra en stamme af slaegten streptomyces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58089075A JPS59216597A (ja) 1983-05-23 1983-05-23 新生理活性物質ヒスタジン

Publications (2)

Publication Number Publication Date
JPS59216597A true JPS59216597A (ja) 1984-12-06
JPH0358342B2 JPH0358342B2 (en, 2012) 1991-09-05

Family

ID=13960733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58089075A Granted JPS59216597A (ja) 1983-05-23 1983-05-23 新生理活性物質ヒスタジン

Country Status (5)

Country Link
EP (1) EP0127076A3 (en, 2012)
JP (1) JPS59216597A (en, 2012)
DK (1) DK251384A (en, 2012)
GR (1) GR82026B (en, 2012)
ZA (1) ZA843846B (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007086354A1 (ja) * 2006-01-24 2007-08-02 Nippon Zoki Pharmaceutical Co., Ltd. 新規ヒスチジン誘導体
US8324261B2 (en) 2007-07-23 2012-12-04 Nippon Zoki Pharmaceutical Co., Ltd. Histidine derivatives

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163661A (ja) * 1984-09-05 1986-04-01 Microbial Chem Res Found ヒスタジン関連化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2367492A1 (fr) * 1976-10-12 1978-05-12 Stanley Drug Products Inc Derives de l'histidine utilisables pour lutter contre les infections microbiennes.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007086354A1 (ja) * 2006-01-24 2007-08-02 Nippon Zoki Pharmaceutical Co., Ltd. 新規ヒスチジン誘導体
US8236844B2 (en) 2006-01-24 2012-08-07 Nippon Zoki Pharmaceutical Co., Ltd. Histidine derivatives
US8324261B2 (en) 2007-07-23 2012-12-04 Nippon Zoki Pharmaceutical Co., Ltd. Histidine derivatives

Also Published As

Publication number Publication date
ZA843846B (en) 1985-02-27
DK251384A (da) 1984-11-24
GR82026B (en, 2012) 1984-12-12
EP0127076A3 (en) 1987-04-29
EP0127076A2 (en) 1984-12-05
DK251384D0 (da) 1984-05-22
JPH0358342B2 (en, 2012) 1991-09-05

Similar Documents

Publication Publication Date Title
US4254256A (en) Amino sugar compound
WO1999025719A1 (fr) Substance physiologiquement active, la sulphostine, procede de fabrication et utilisation
US4019960A (en) Process for the production of a saccharase inhibitor
JP2802097B2 (ja) 新規な制癌抗生物質ｍｉ４３―３７ｆ１１及びその製造法
JPS59216597A (ja) 新生理活性物質ヒスタジン
US4595698A (en) Physiologically active substance, arphamenine and production thereof
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
US4415557A (en) Antibiotic compound, its production and its medicinal use
JPS60246396A (ja) 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類
JPS6261037B2 (en, 2012)
CN102086441B (zh) 一种灰褐链霉菌菌株、及利用该菌株制备ε-聚赖氨酸及其盐的方法
US4416870A (en) Antibiotic compound, its production and its medicinal use
NO132240B (en, 2012)
IL38693A (en) Antibiotic a-4696
JPS6316399B2 (en, 2012)
JPH0429356B2 (en, 2012)
KR870002170B1 (ko) 발효법에 의한 분말 간장의 제조방법
NO822016L (no) Nye antibiotisk virksomme forbindelser, fremgangsmaate til deres fremstilling samt deres anvendelse som legemidler
JPH0258280B2 (en, 2012)
JPS62114947A (ja) Ｄ−ベ−タ−リジルメタンジアミンおよびその製造法
KR790001354B1 (ko) 항생제 복합제의 제조방법
US3616230A (en) Method for production of l-asparaginase
JPH0630603B2 (ja) ヒアルロン酸の製造法
JPH0733395B2 (ja) 抗生物質ｔａｎ−９２８およびその製造法
JPH01206996A (ja) １．３―ジヒドロキシ―８―デセン―５―オンを含む免疫賦活剤及び制癌剤